摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-bromo-4-oxo-4,5,6,7-tetrahydrothieno[2,3-b]thiepin-5-acetic acid | 135301-31-4

分子结构分类

中文名称
——
中文别名
——
英文名称
2-bromo-4-oxo-4,5,6,7-tetrahydrothieno[2,3-b]thiepin-5-acetic acid
英文别名
2-(2-bromo-4-oxo-6,7-dihydro-5H-thieno[2,3-b]thiepin-5-yl)acetic acid
2-bromo-4-oxo-4,5,6,7-tetrahydrothieno[2,3-b]thiepin-5-acetic acid化学式
CAS
135301-31-4
化学式
C10H9BrO3S2
mdl
——
分子量
321.216
InChiKey
AYURVPDFCFURSX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    108
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Thiophene compounds and their pharmaceutical uses
    申请人:YOSHITIOMI PHARMACEUTICAL INDUSTRIES, LTD.
    公开号:EP0426018A2
    公开(公告)日:1991-05-08
    Thiophene compounds of the formula: wherein R¹ is hydrogen, nitro, amino, halogen or C₁₋₄ alkyl; R² is hydrogen, nitro, amino, halogen, C₁₋₄ alkyl, C₁₋₄ haloalkyl, acyl, C₂₋₅ alkoxycarbonyl, C₁₋₄ alkoxy-C₁₋₄ alkyl, aryloxy-C₁₋₄ alkyl, acyloxy-C₁₋₄ alkyl, hydroxy-C₁₋₄ alkyl, acyloxy-C₂₋₅ alkanoyl, C₁₋₄ alkoxy-C₂₋₅ alkanoyl, hydroxy-­C₂₋₅ alkanoyl, aryloxy-C₂₋₅ alkanoyl or C₂₋₅ haloalkanoyl; R³ is hydrogen, C₁₋₈ alkyl, hydroxy-C₁₋₄ alkyl, C₂₋₅ alkanoyloxy-C₁₋₄ alkyl, aryl, aryl-C₁₋₄ alkyl, heteroaryl, heteroaryl-C₁₋₄ alkyl or aryl, aryl-C₁₋₄ alkyl, heteroaryl or heteroaryl-C₁₋₄ alkyl substituted by at least one substituent selected from the group consisting of halogen, hydroxy, amino, nitro, cyano, C₁₋₄ alkyl, C₁₋₄ alkoxy, C₂₋₅ alkanoylamino, C₁₋₄ haloalkyl, acyloxy, C₂₋₅ alkoxycarbonyl and carboxyl on the aromatic ring; m is 0, 1 or 2; n is 1 or 2; the bond represented by --- is a single bond or a double bond. Thiophene compounds (I) are useful as antianxiety drugs, hypnotics, antiepileptic drugs or nootropics. Thiophene compounds ( II ) are useful as intermediates for said thiophene compounds (I).
    式中的噻吩化合物: 其中 R¹ 是氢、硝基、基、卤素或 C₁₋₄ 烷基;R² 是氢、硝基、基、卤素、C₁₋₄ 烷基、C₁₋₄ 卤代烷基、酰基、C₂₋₅ 烷氧基羰基、C₁₋₄ 烷氧基-C₁₋₄ 烷基、芳氧基-C₁₋₄ 烷基、酰氧基-C₁₋₄ 烷基、羟基-C₁₋₄烷基、酰氧基-C₂₋₅ 烷酰基、C₁₋₄烷氧基-C₂₋₅ 烷酰基、羟基-C₂₋₅ 烷酰基、芳氧基-C₂₋₅ 烷酰基或 C₂₋₅ 卤代烷酰基;R³ 是氢、C₁₋₈烷基、羟基-C₁₋₄ 烷基、C₂₋₅烷酰氧基-C₁₋₄ 烷基、芳基、芳基-C₁₋₄ 烷基、杂芳基、杂芳基-C₁₋₄ 烷基或芳基、芳基-C₁₋₄ 烷基、杂芳基或杂芳基-C₁₋₄烷基被至少一个选自卤素、羟基、基、硝基、基组成的取代基取代、C₁₋₄ 烷基、C₁₋₄ 烷氧基、C₂₋₅烷酰基、C₁₋₄ 卤代烷基、酰氧基、C₂₋₅烷氧羰基和芳香环上的羧基;m 是 0、1 或 2;n 是 1 或 2;由----表示的键是单键或双键。 噻吩化合物(I)可用作抗焦虑药、催眠药、抗癫痫药或促智药。噻吩化合物(II)可用作上述噻吩化合物(I)的中间体。
  • Thiophene compounds and their use as intermediates in the preparation of antianxiety drugs, hypnotics, antiepileptic drugs and nuotropics
    申请人:YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.
    公开号:EP0729960A1
    公开(公告)日:1996-09-04
    Thiophene compounds of the formula: wherein R1 is hydrogen, nitro, amino, halogen or C1-4 alkyl; R2 is hydrogen, nitro, amino, halogen, C1-4 alkyl, C1-4 haloalkyl, acyl, C2-5 alkoxycarbonyl, C1-4 alkoxy-C1-4 alkyl, aryloxy-C1-4 alkyl, acyloxy-C1-4 alkyl, hydroxy-C1-4 alkyl, acyloxy-C2-5 alkanoyl, C1-4 alkoxy-C2-5 alkanoyl, hydroxy-C2-5 alkanoyl, aryloxy-C2-5 alkanoyl or C2-5 haloalkanoyl; R3 is hydrogen, C1-8 alkyl, hydroxy-C1-4 alkyl, C2-5 alkanoyloxy-C1-4 alkyl, aryl, aryl-C1-4 alkyl, heteroaryl, heteroaryl-C1-4 alkyl or aryl, aryl-C1-4 alkyl, heteroaryl or heteroaryl-C1-4 alkyl substituted by at least one substituent selected from the group consisting of halogen, hydroxy, amino, nitro, cyano, C1-4 alkyl, C1-4 alkoxy, C2-5 alkanoylamino, C1-4 haloalkyl, acyloxy, C2-5 alkoxycarbonyl and carboxyl on the aromatic ring; m is 0, 1 or 2; n is 1 or 2; the bond represented by ---- is a single bond or a double bond. Thiophene compounds () are useful as antianxiety drugs, hypnotics, antiepileptic drugs or nootropics. Thiophene compounds () are useful as intermediates for said thiophene compounds ().
    式中的噻吩化合物: 其中R1是氢、硝基、基、卤素或C1-4烷基;R2是氢、硝基、基、卤素、C1-4烷基、C1-4卤代烷基、酰基、C2-5烷氧基羰基、C1-4烷氧基-C1-4烷基、芳氧基-C1-4烷基、酰氧基-C1-4烷基、羟基-C1-4烷基、酰氧基-C2-5烷酰基、C1-4烷氧基-C2-5烷酰基、羟基-C2-5烷酰基、芳氧基-C2-5烷酰基或C2-5卤代烷酰基;R3 是氢、C1-8 烷基、羟基-C1-4 烷基、C2-5 烷酰氧基-C1-4 烷基、芳基、芳基-C1-4 烷基、杂芳基、杂芳基-C1-4 烷基或芳基、芳基-C1-4 烷基、在芳香环上被至少一个取代基取代的杂芳基或杂芳基-C1-4 烷基,该取代基选 自卤素、羟基、基、硝基、基、C1-4 烷基、C1-4 烷氧基、C2-5 烷酰基、C1-4 卤代烷基、酰氧基、C2-5 烷氧羰基和羧基组成的组;m 是 0、1 或 2;n 是 1 或 2;---- 所代表的键是单键或双键。 噻吩化合物()可用作抗焦虑药、催眠药、抗癫痫药或健脑药。噻吩化合物()可用作上述噻吩化合物()的中间体。
  • US5175162A
    申请人:——
    公开号:US5175162A
    公开(公告)日:1992-12-29
  • US5329016A
    申请人:——
    公开号:US5329016A
    公开(公告)日:1994-07-12
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (反式)-4-壬烯醛 (双(2,2,2-三氯乙基)) (乙腈)二氯镍(II) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (±)17,18-二HETE (±)-辛酰肉碱氯化物 (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (s)-2,3-二羟基丙酸甲酯 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 ([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) ([1-(甲氧基甲基)-1H-1,2,4-三唑-5-基](苯基)甲酮) (Z)-5-辛烯甲酯 (Z)-4-辛烯醛 (Z)-4-辛烯酸 (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-氨氯地平-d4 (S)-氨基甲酸酯β-D-O-葡糖醛酸 (S)-8-氟苯并二氢吡喃-4-胺 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(((2,2-二氟-1-羟基-7-(甲基磺酰基)-2,3-二氢-1H-茚满-4-基)氧基)-5-氟苄腈 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯